Pharmacokinetics of SP-104
Clinical trial NCT05002946 · COMPLETED
Trial details
- NCT number
- NCT05002946
- Sponsor
- Scilex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2022-04-24
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.